Notes to the individual financial statements

1 Principles

These financial statements were prepared according to the principles of the Swiss Law on Accounting and Financial Reporting (32nd title of the Swiss Code of Obligations). Where not prescribed by law, the significant accounting and measurement principles applied are described below. It should be noted that to ensure the company's going concern, the company may create and release hidden reserves.

The company was registered in the commercial register on 28 January 2020. The first financial year 2020 (comparative period) encompasses the period from 28 January to 31 December 2020.

In accordance with Article 961 (1) CO, no further disclosures are made in the notes, cash flow statement and directors' report because Ina Invest Holding Ltd prepares its consolidated financial statements in accordance with Swiss GAAP FER and is listed at the Swiss stock exchange SIX.

This item includes bank deposits with a maximum residual term of of 90 days. These are recognised and measured at nominal value.

The Investment in Ina Invest Ltd is measured at the lower of acquisition cost or net market value. If there is an indication that the carrying amount may be overstated, it is reviewed and, if necessary, an impairment is recognised.

Treasury shares are recognised at acquisition cost and deducted from equity at the time of acquisition. In case of a resale, the gain or loss is recognised through the income statement as financial income or financial expenses.

Share-based payments paid with equity instruments are measured at their fair value prevailing on the day of the grant and recognised as personnel expenses over the vesting period. The grant date fair value is determined using valuation models that are based on the registered shares’ market rates at grant date.

Any pro rata expenses accrued are deferred as of the balance sheet date. Should treasury shares be used for share-based payments made to Board members and employees, the difference between the acquisition costs and the market value at grant date is recognised as financial expenses or financial income.

 

2 Information on balance sheet and income statement items

in CHF thousands 2021 2020
Items charged to companies in which the entity holds an investment 2,534 614
Total other income 2,534 614

This item includes personnel expenses and other operating expenses charged to Ina Invest Ltd.

in CHF thousands 2021 2020
Wages and salaries (961) (532)
Share-based payments (257) (127)
Pensions expenses (85) (49)
Social security expenses (105) (61)
Other personnel expenses (36) (21)
Total personnel expenses (1,444) (789)

 

in CHF thousand 2021 2020
Capital increase expenses (32) (6,389)
Expenses general assembly (40) -
Accounting and consulting expenses (429) (584)
Marketing (392) (64)
Administrative expenses (66) (26)
Total other operating expenses (959) (7,063)

 

in CHF thousands 31.12.2021 31.12.2020
VAT receivables 11 6
Receivables from third parties 2 -
Receivables from companies in which the entity holds an investment 71 192
Total other current receivables 84 198

 

in CHF thousands 31.12.2021 31.12.2020
Receivables from third parties - 4
Receivables from companies in which the entity holds an investment 1,278 436
Total accrued income and prepaid expenses 1,278 440

 

Company, domicile Capital in CHF thousands     Votes and capital share
31.12.2021 31.12.2020 31.12.2021 31.12.2020
Ina Invest Ltd. Zurich 202 202 57.5% 57.5%

Implenia Ltd is the minority shareholder that holds the remaining voting rights and shares in Ina Invest Ltd (42.5%; 31 December 2020: 42.5%).

in CHF thousands 31.12.2021 31.12.2020
Liabilities due to third parties - 15
Total trade accounts payable - 15

 

in CHF thousands 31.12.2021 31.12.2020
Liabilities due to third parties 84 59
Total other current liabilities 84 59

 

in CHF thousands 31.12.2021 31.12.2020
Liabilities due to third parties 478 524
Liabilities due to governing bodies 138 110
Total accrued expenses and deferred income 616 634

 

in CHF thousands 31.12.2021 31.12.2020
Liabilities to companies in which the entity holds an investment 1,539 539
Total non-current interest-bearing financial liabilities 1,539 539

 

in CHF thousands 31.12.2021 31.12.2020
8,866,560 registered shares at a nominal value of CHF 0.03 266 266
Total share capital 266 266

Authorised share capital

In accordance with the Company’s Articles of Association, the Board of Directors is entitled to increase the share capital by a maximum of CHF 53,199.36 at any time until 2 June 2022 by issuing up to 1,773,312 registered shares with a nominal value of CHF 0.03 each, which are to be fully paid up.

Several increases, each worth part of this amount, are permitted. The Board of Directors determines the issue amount, the type of contributions, the timing of the issue, the criteria for exercising subscription rights and the time at which a dividend entitlement starts to apply. In the case of a capital increase from authorised capital, the Board of Directors is entitled to withdraw or restrict shareholders’ subscription rights up to a maximum of 886,656 registered shares provided certain criteria set out in the Articles of Association are met.
 

Conditional share capital

In accordance with the Company’s Articles of Association, the conditional share capital can be increased by a maximum of CHF 13,299.84 by issuing up to 443,328 registered shares with a nominal value of CHF 0.03 each, which are to be fully paid up. Such an increase is to be carried out by exercising option rights granted to employees or members of the Board of Directors of the Company or group companies.

in CHF thousands 31.12.2021 31.12.2020
Reserves from capital contributions 120,330 120,330
Other capital reserves 6,366 6,366
Total statutory capital reserves 126,696 126,696

The reserves from the capital contribution have been duly reported to the Swiss Federal Tax Administration. However, they have not been recognised in accordance with Article 5(1) Withholding Tax Act at the time of closing of the comparative period. In the reporting period, the Swiss Federal Tax Administration recognised CHF 120,330 thousand as reserves from capital contributions, while the remaining unrecognised CHF 6,366 thousand are reported as other capital reserves. Due to the confirmation in the current fiscal year, the comparative period has been adjusted accordingly.

Number of registered shares Ø transaction price in CHF 2021 2020
Balance as at 01.01. 9,500 -
Acquisition of treasury shares 18.62 8,542 9,500
Transfer of vested shares - (8,084) -
Balance as at 31.12. 9,958 9,500

The transaction price always corresponded to the market price. As at 31 December 2021, the carrying amount corresponded to CHF 185 thousand (31 December 2020: CHF 165 thousand).

 

3 Other information

The annual average number of full-time equivalents was below 10 for the reporting year and the comparative period.

Shareholder 31.12.2021
Votes
31.12.2020
Votes
Max Rössler 16.56% 16.56%
Swiss Life Holding AG 15.09% 15.09%
Norbert Ketterer 12.52% 12.52%
Rudolf Maag 5.41% 5.41%
CACEIS (Switzerland) SA 5.06% 5.06%

 

Board of Directors 31.12.2021
Number of shares
31.12.2020
Number of shares
Stefan Mächler, Chairman of the Board of Directors 11,939 9,000
Christoph Caviezel, Vice Chairman of the Board of Directors 3,950 2,480
Hans Ulrich Meister, member of the Board of Directors 38,264 36,941
André Wyss, member of the Board of Directors 47,797 46,768
Marie-Noëlle Zen-Ruffinen, member of the Board Directors 1,323 -
Management

31.12.2021
Number of shares

31.12.2020
Number of shares
Marc Pointet, CEO - -

The Board members as well as the CEO receive shares or options on shares, which are allocated in the framework of their share-based payments. Further explanations in this respect may be found in the notes to the consolidated annual report prepared in accordance with Swiss GAAP FER (note 4.2) as well as the Compensation Report. No conversion or option rights for member of the Board or Management existed as at 31 December 2020. 

The following are the details of the allocation:

  31.12.21
Number
of shares
31.12.21
Value in TCHF
Allocated to members of the Board of Directors 8’084 157
Allocated to Group Management - -

The shares were allocated to the members of the Board of Directors on 4 January 2021.

  31.12.21
Number
of shares
31.12.21
Value in TCHF
Allocated to members of the Board of Directors - -
Allocated to Group Management 3,182 38

The shares (RSU) were allocated to the CEO on 15 March 2021.

The expenses from the CEO's share-based payment is recognised over the vesting period. As of the balance sheet date of 31 December 2021, a liability of CHF 38 thousand (31 December 2020: CHF 17 thousand) was recognised from this allocation.

Each financial year, Implenia Group may sell up to 5% of its investment in Ina Invest Ltd to Invest Holding Ltd (put option). In doing so, the Company may decide whether it prefers cash or Ina Invest Holding shares in consideration. If Implenia Group exercises the put option, the sales price will equal the implicit market value of Ina Invest Ltd. The implicit market value will be determined based on the share price of Ina Invest Holding Ltd. As at 31 December 2021, the value of the associated contingent liability is estimated at CHF 122,416 thousand (31 December 2020: CHF 119,599 thousand).

There are no significant events after the balance sheet date which could impact the book value of the assets or liabilities or which should be disclosed here.

 

Proposed appropriation of available earnings

TCHF 31.12.2021 31.12.2020
Loss carried forward (7,266) -
Result for the year 103 (7,266)
Total at the disposal of the general assembly (7,163) (7,266)

 

TCHF 31.12.2021 31.12.2020
Balance sheet loss (7,163) (7,266)
./.Allocation to legal reserves - -
./. Allocation to statutory retained earnings - -
./. Dividend payments - -
Balance carryforward (7,163) (7,266)

 

nach oben
Accept

This website uses cookies. More information about how and why cookies are used and how you can change your cookie settings can be found via the following link in the cookie information section. By using this website or clicking the button below, you agree to the use of cookies and to our Privacy Policy.